You have 9 free searches left this month | for more free features.

Clostridium difficile disease

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clostridium Difficile Colonization, Clostridium Difficile Diarrhea Trial in Hamilton (Vancomycin, Culturelle, Vancomycin

Not yet recruiting
  • Clostridium Difficile Colonization
  • Clostridium Difficile Diarrhea
  • Hamilton, Ontario, Canada
  • +1 more
Aug 4, 2022

Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea Trial in Charlottesville

Recruiting
  • Clostridioides Difficile Infection
  • +3 more
  • Charlottesville, Virginia
    UVA Health Systems
Nov 2, 2022

REMBRANDT: REcovery of MicroBiome fRom Antibiotics for Dental

Recruiting
  • Dysbiosis
  • +3 more
    • Philadelphia, Pennsylvania
      The Robert Schattner Center, University of Pennsylvania, School
    Nov 16, 2022

    Clostridium Difficile Trial in St. John's (Fecal Microbiota Transplantation, Vancomycin, Fecal Microbiota Transplantation

    Withdrawn
    • Clostridium Difficile
    • Fecal Microbiota Transplantation
    • +3 more
    • St. John's, Newfoundland and Labrador, Canada
      Health Sciences Centre
    Apr 22, 2022

    Clostridium Difficile Infections, Stem Cell Transplant Complications Trial (Vancomycin, Placebo)

    Not yet recruiting
    • Clostridium Difficile Infections
    • Stem Cell Transplant Complications
    • (no location specified)
    Feb 17, 2022

    Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota

    Active, not recruiting
    • Allogeneic Hematopoietic Stem Cell
    • fecal microbiota transplantation (FMT)
    • No fecal microbiota transplantation (FMT), routine management
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 25, 2022

    Active C. Difficile Colitis Trial in Houston (Microbiota Transplantation (FMT))

    Enrolling by invitation
    • Active C. Difficile Colitis
    • Microbiota Transplantation (FMT)
    • Houston, Texas
      Michael E DeBakey Veterans Affairs Medical Center
    Feb 24, 2022

    Immune Response to C.Difficile Infection

    Recruiting
    • Clostridium Difficile
      • Charlottesville, Virginia
        University of Virginia Health System
      May 31, 2022

      Clostridium Difficile Trial in Chapel Hill (Stool specimen)

      Completed
      • Clostridium Difficile
      • Stool specimen
      • Chapel Hill, North Carolina
        UNC Chapel Hill
      Mar 25, 2022

      Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile

      Completed
      • Clostridium Infections
      • C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
      • +2 more
      • Gent, Belgium
        GSK Investigational Site
      Jun 9, 2022

      Clostridioides Difficile Infection Trial in Leiden (biological, other, drug)

      Not yet recruiting
      • Clostridioides Difficile Infection
      • 10E4 NTCD spores
      • +3 more
      • Leiden, Netherlands
        Leiden University Medical Center
      Jan 11, 2023

      Clostridium Difficile Trial in Bronx (Bezlotoxumab)

      Terminated
      • Clostridium Difficile
      • Bronx, New York
        Montefiore Medical Center
      Oct 13, 2022

      Primary Clostridioides Difficile Infection (pCDI) Trial (Lyophilized fecal microbiome transfer, Vancomycin)

      Not yet recruiting
      • Primary Clostridioides Difficile Infection (pCDI)
      • (no location specified)
      Jan 24, 2023

      Clostridium Difficile Trial in Miami, Chicago (Serum-derived bovine immunoglobulin/protein isolate (SBI), Placebo)

      Terminated
      • Clostridium Difficile
      • Serum-derived bovine immunoglobulin/protein isolate (SBI)
      • Placebo
      • Miami, Florida
      • +2 more
      Nov 10, 2021

      Clostridium Difficile Infections in Hospitalized Patients on

      Completed
      • Clostridium Difficile
      • no intervention
      • La Roche-sur-Yon, France
      • +33 more
      May 18, 2021

      Clostridium Difficile Infection, Ulcerative Colitis, Indeterminate Colitis Trial in Stony Brook (Fecal Microbial

      Completed
      • Clostridium Difficile Infection
      • +2 more
      • Fecal Microbial Transplantation
      • Stony Brook, New York
        Stony Brook University Hospital
      Feb 21, 2022

      REBYOTA™ Prospective Registry

      Not yet recruiting
      • Recurrence of Clostridium Difficile Infection
      • (no location specified)
      Apr 18, 2023

      FQ Restriction for the Prevention of CDI

      Enrolling by invitation
      • Clostridium Difficile
      • +2 more
      • fluoroquinolone preprescription authorization
      • Control
      • Phoenix, Arizona
      • +7 more
      Mar 2, 2022

      Clostridium Difficile Infection Recurrence Trial in North Little Rock, Shreveport (RBX2660)

      Recruiting
      • Clostridium Difficile Infection Recurrence
      • North Little Rock, Arkansas
      • +1 more
      Apr 27, 2023

      Clostridium Difficile Infection Trial in Minneapolis (Fecal Microbiota Therapy (FMT), Placebo)

      Recruiting
      • Clostridium Difficile Infection
      • Fecal Microbiota Therapy (FMT)
      • Placebo
      • Minneapolis, Minnesota
        Minneapolis VA Health Care System, Minneapolis, MN
      Mar 3, 2022

      Clostridioides Difficile Infection Trial (LMN-201, Placebo)

      Not yet recruiting
      • Clostridioides Difficile Infection
      • (no location specified)
      Nov 15, 2022

      Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile Vaccine, Placebo)

      Completed
      • Clostridium Difficile Associated Disease
      • Clostridium difficile Vaccine
      • Placebo
      • DeLand, Florida
      • +16 more
      Feb 11, 2021

      Recipients Gut Microbiota After Fecal Microbiota Transplantation

      Recruiting
      • Clostridioides Difficile Infection Recurrence
      • FMT from healthy donors
      • Roma, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Feb 13, 2023

      Clostridium Difficile Infection Recurrence Trial in Royal Oak (Bacillus velezensis DSM 33864, Placebo)

      Not yet recruiting
      • Clostridium Difficile Infection Recurrence
      • Bacillus velezensis DSM 33864
      • Placebo
      • Royal Oak, Michigan
        Beaumont Hospital
      Dec 5, 2022

      Clostridioides Difficile Infection Trial in Canada, United States (CRS3123, Active Comparator)

      Recruiting
      • Clostridioides Difficile Infection
      • Fullerton, California
      • +24 more
      Jun 28, 2022